Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sheikh

Showing results (291-300 of 308) with videos related to

Pageof 31
Sort By:
The Journal of Invasive Cardiology|November 23, 2022
Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary InterventionSpyridon Kostantinis, Bahadir Simsek, Judit Karacsonyi, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III studyDavid R Nelson, James N Cooper, Jacob P Lalezari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 30, 2020
Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registryIlias Nikolakopoulos, James W Choi, Khaldoon Alaswad, et al.
Nature Medicine|February 16, 2023
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trialArun J Sanyal, Patricia Lopez, Eric J Lawitz, et al.
The Journal of Invasive Cardiology|June 23, 2020
Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical OutcomesIosif Xenogiannis, Ilias Nikolakopoulos, Oleg Krestyaninov, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 25, 2023
Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO RegistryJudit Karacsonyi, Khaldoon Alaswad, Oleg Krestyaninov, et al.
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trialEric Lawitz, Jay P Lalezari, Tarek Hassanein, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 2, 2022
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registrySpyridon Kostantinis, Bahadir Simsek, Judit Karacsonyi, et al.
The Journal of Invasive Cardiology|August 26, 2021
Distal Radial Access in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO RegistryIlias Nikolakopoulos, Taral Patel, Brian K Jefferson, et al.
Journal of Personalized Medicine|March 29, 2023
Angiographic Features and Clinical Outcomes of Balloon Uncrossable Lesions during Chronic Total Occlusion Percutaneous Coronary InterventionJudit Karacsonyi, Spyridon Kostantinis, Bahadir Simsek, et al.
Pageof 31

Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Invasive Cardiology|November 23, 2022
Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary InterventionSpyridon Kostantinis, Bahadir Simsek, Judit Karacsonyi, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III studyDavid R Nelson, James N Cooper, Jacob P Lalezari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 30, 2020
Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registryIlias Nikolakopoulos, James W Choi, Khaldoon Alaswad, et al.
Nature Medicine|February 16, 2023
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trialArun J Sanyal, Patricia Lopez, Eric J Lawitz, et al.
The Journal of Invasive Cardiology|June 23, 2020
Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical OutcomesIosif Xenogiannis, Ilias Nikolakopoulos, Oleg Krestyaninov, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 25, 2023
Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO RegistryJudit Karacsonyi, Khaldoon Alaswad, Oleg Krestyaninov, et al.
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trialEric Lawitz, Jay P Lalezari, Tarek Hassanein, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 2, 2022
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registrySpyridon Kostantinis, Bahadir Simsek, Judit Karacsonyi, et al.
The Journal of Invasive Cardiology|August 26, 2021
Distal Radial Access in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO RegistryIlias Nikolakopoulos, Taral Patel, Brian K Jefferson, et al.
Journal of Personalized Medicine|March 29, 2023
Angiographic Features and Clinical Outcomes of Balloon Uncrossable Lesions during Chronic Total Occlusion Percutaneous Coronary InterventionJudit Karacsonyi, Spyridon Kostantinis, Bahadir Simsek, et al.
Pageof 31